Ghrelin is the only known hormone that requires a lipid modification for its primary activity, and that feature shapes everything about how it must be handled.
Key Takeaways
- Ghrelin was identified as the endogenous ligand for the growth hormone secretagogue receptor and is produced mainly by gastric enteroendocrine cells.
- Des-acyl ghrelin circulates at higher concentration and has been studied for effects distinct from the acylated form, though its receptor remains less clearly defined.
- Any ghrelin experiment must state which form was measured and how deacylation was prevented.
Discovery and form
Ghrelin was identified as the endogenous ligand for the growth hormone secretagogue receptor and is produced mainly by gastric enteroendocrine cells. It circulates in both acylated and des-acylated forms, and only the acylated form activates the classical receptor.
Why octanoylation matters
A serine residue is esterified with octanoic acid, a modification introduced by ghrelin O-acyltransferase. Without it the peptide is essentially inactive at the growth hormone secretagogue receptor, which is a rare and consequential example of essential lipidation.
For related mechanism work, see PTH analogues bone research.
Two circulating forms
Des-acyl ghrelin circulates at higher concentration and has been studied for effects distinct from the acylated form, though its receptor remains less clearly defined. Assays must distinguish the two, and many published measurements do not.
Assay and stability problems
The acyl ester is labile and hydrolyses in plasma, and sample handling determines how much acylated ghrelin remains at measurement. Acidification and protease inhibition during collection are standard precautions rather than refinements.
Research implications
Any ghrelin experiment must state which form was measured and how deacylation was prevented. Failure to control this is one of the most common sources of irreproducible results in the field.
Experimental Conditions and Practical Setup
Blood is collected into tubes containing a protease inhibitor and acidified immediately, because the acyl ester hydrolyses rapidly in plasma. Assays are selected to distinguish acylated from des-acyl ghrelin, and results are reported separately for each form rather than as a total, since only the acylated form activates the classical receptor.
Pre-analytical controls for ghrelin measurement
| Step | Purpose | Failure mode |
|---|---|---|
| Protease inhibitor at collection | Prevent peptide degradation | Underestimation of both forms |
| Immediate acidification | Preserve the acyl ester | Loss of the acylated fraction |
| Assay specific to each form | Distinguish active from inactive | Total values obscure the active form |
| Cold processing and rapid freezing | Limit ex vivo change | Form interconversion |
Practical Notes for the Bench
- State which ghrelin form was measured in any report.
- Acidify and add protease inhibitors during sample collection.
- Prevent acyl-ester hydrolysis or the acylated fraction will be lost.
Frequently Asked Questions
Why are there two forms?
Only the octanoylated form activates the classical receptor; the des-acyl form circulates at higher concentration and has separate, less defined activity.
What is the biggest assay pitfall?
Hydrolysis of the acyl ester during handling, which removes the active form before measurement.
Where is ghrelin produced?
Principally by enteroendocrine cells in the stomach.
Why is ghrelin unusually difficult to measure?
Because the octanoyl ester required for activity hydrolyses in plasma, so handling determines how much active hormone remains at the point of measurement.
Related Reading
- PTH analogues bone research
- calcitonin peptide
- natriuretic peptides
- peptide vaccine design
- evaluating peptide research
References & Further Reading
- Sassi M et al. Ghrelin Acylation-A Post-Translational Tuning Mechanism Regulating Adult Hippocampal Neurogenesis. Cells. 2022. PubMed 35269387
- Al Massadi O et al. Ghrelin acylation and metabolic control. Peptides. 2011. PubMed 21893140
- Davis TR et al. Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling. Open Biol. 2021. PubMed 34315274
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
Educational content for research staff. Nothing here should be read as advice on human or veterinary use of any compound.
Reviewed by Priya Raghunathan, MSc, Formulation & Stability Science.